[Federal Register: August 11, 2004 (Volume 69, Number 154)]
[Notices]
[Page 48874-48875]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11au04-82]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-04-04JW]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 498-1210 or send an e-mail to omb@cdc.gov.
CDC is requesting an emergency clearance for this data collection
with a two week public comment period. CDC is requesting OMB approval
of this
[[Page 48875]]
package 7 days after the end of the public comment period. While there
is currently no SARS outbreak, expedited clearance is needed because
the season when SARS outbreaks are most likely to occur is quickly
approaching.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Send comments to Seleda M. Perryman,
CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-E11,
Atlanta, GA 30333. Written comments should be received within 14 days
of this notice.
Proposed Project
SARS Laboratory Safety Survey--New--National Center for Infectious
Diseases (NCID), Centers for Disease Control and Prevention (CDC).
During the past year, incidents of lab-acquired SARS-CoV infection
have occurred at research institutions in China, Singapore, and Taiwan.
As part of measures taken by CDC to prevent lab-acquired SARS
infections in the United States, the Respiratory and Enteric Virus
Branch (REVB) would like to collect information on current biosafety
practices and use of live SARS-CoV from U.S. institutions that have
obtained the virus, either from CDC or from other sources.
Response data will be used to determine to what extent research
involving live SARS-CoV and other biosafety level 3 pathogens is being
conducted, the safety of the research environment, information about
biosafety training, and the level of lab worker experience with BSL-3
pathogens. Expedited collection of this information is necessary to
ascertain the safety of environments where live SARS-CoV research may
be taking place and to potentially address any deficiencies that may
exist. There is no cost to the respondents.
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Form Respondent No. of responses/ response (in Total burden
respondents respondent hrs.) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Safety Survey for Laboratories Conducting Laboratorians........................ 120 1 10/60 20
Research with live SARS-CoV and Other BSL-3
Pathogens.
----------------------------------------
Total.................................... ..................................... ............... ............... ............... 20
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: August 4, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-18331 Filed 8-10-04; 8:45 am]
BILLING CODE 4163-18-P